CL2007003348A1 - Procedimiento de preparacion de 4,4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona); compuesto intermediario; procedimiento de preparacion y uso. - Google Patents

Procedimiento de preparacion de 4,4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona); compuesto intermediario; procedimiento de preparacion y uso.

Info

Publication number
CL2007003348A1
CL2007003348A1 CL200703348A CL2007003348A CL2007003348A1 CL 2007003348 A1 CL2007003348 A1 CL 2007003348A1 CL 200703348 A CL200703348 A CL 200703348A CL 2007003348 A CL2007003348 A CL 2007003348A CL 2007003348 A1 CL2007003348 A1 CL 2007003348A1
Authority
CL
Chile
Prior art keywords
preparation
procedure
piperazindiona
etandyl
bis
Prior art date
Application number
CL200703348A
Other languages
English (en)
Spanish (es)
Inventor
Koch Erwin Neufellner Andreas
Original Assignee
Cyathus Exquirere Pharmaforsch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39048046&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2007003348(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Cyathus Exquirere Pharmaforsch filed Critical Cyathus Exquirere Pharmaforsch
Publication of CL2007003348A1 publication Critical patent/CL2007003348A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/16—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of hydrocarbon radicals substituted by amino or carboxyl groups, e.g. ethylenediamine-tetra-acetic acid, iminodiacetic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL200703348A 2006-11-24 2007-11-23 Procedimiento de preparacion de 4,4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona); compuesto intermediario; procedimiento de preparacion y uso. CL2007003348A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ATA1958/2006A AT504621B1 (de) 2006-11-24 2006-11-24 Neues verfahren zur herstellung von 4,4'-(1-methyl -1,2-ethandiyl)-bis-(2,6-piperazindion)

Publications (1)

Publication Number Publication Date
CL2007003348A1 true CL2007003348A1 (es) 2008-06-06

Family

ID=39048046

Family Applications (1)

Application Number Title Priority Date Filing Date
CL200703348A CL2007003348A1 (es) 2006-11-24 2007-11-23 Procedimiento de preparacion de 4,4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona); compuesto intermediario; procedimiento de preparacion y uso.

Country Status (24)

Country Link
US (1) US8455641B2 (cg-RX-API-DMAC7.html)
EP (1) EP2099773B1 (cg-RX-API-DMAC7.html)
JP (1) JP2010510253A (cg-RX-API-DMAC7.html)
KR (1) KR20090119828A (cg-RX-API-DMAC7.html)
CN (1) CN101563329B (cg-RX-API-DMAC7.html)
AR (1) AR063927A1 (cg-RX-API-DMAC7.html)
AT (1) AT504621B1 (cg-RX-API-DMAC7.html)
AU (1) AU2007324322A1 (cg-RX-API-DMAC7.html)
BR (1) BRPI0719153A2 (cg-RX-API-DMAC7.html)
CA (1) CA2670282A1 (cg-RX-API-DMAC7.html)
CL (1) CL2007003348A1 (cg-RX-API-DMAC7.html)
CO (1) CO6220854A2 (cg-RX-API-DMAC7.html)
ES (1) ES2651245T3 (cg-RX-API-DMAC7.html)
IL (1) IL198908A0 (cg-RX-API-DMAC7.html)
MA (1) MA31015B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009005423A (cg-RX-API-DMAC7.html)
NO (1) NO20092076L (cg-RX-API-DMAC7.html)
NZ (1) NZ577293A (cg-RX-API-DMAC7.html)
PE (1) PE20081497A1 (cg-RX-API-DMAC7.html)
TW (1) TWI491607B (cg-RX-API-DMAC7.html)
UA (1) UA102509C2 (cg-RX-API-DMAC7.html)
UY (1) UY30740A1 (cg-RX-API-DMAC7.html)
WO (1) WO2008061270A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200903780B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012081036A2 (en) * 2010-12-13 2012-06-21 Sequent Scientific Limited A process for preparation of 4,4'-(1-methyl-1,2-ethandiyl)-bis-(2,6-piperazinedione)
CN102952088B (zh) * 2012-06-26 2015-05-27 江苏奥赛康药业股份有限公司 右丙亚胺的制备方法
CZ2013171A3 (cs) * 2013-03-07 2014-04-30 Ústav organické chemie a biochemie Akademie věd ČR, v. v. i. Způsob výroby čistých bezvodých enantiomerů kyseliny 1,2-diaminopropan-N,N,N´,N´-tetraoctové
CN104177301B (zh) * 2013-05-22 2016-04-13 江苏奥赛康药业股份有限公司 一种右丙亚胺的制备方法
CN108250094B (zh) * 2018-03-09 2021-01-26 江苏奥赛康药业有限公司 一种哌嗪二酮类化合物的制备方法
CN110804022B (zh) * 2019-11-06 2023-01-17 扬子江药业集团有限公司 一种右丙亚胺的制备方法
CN113336661B (zh) * 2020-03-03 2022-08-05 南京正大天晴制药有限公司 一种四乙酸甲酯类化合物的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2428353A (en) * 1943-06-21 1947-10-07 Frederick C Bersworth Lower aliphatic esters of ethylene-and propylene-diamine n,n'-tetracetic acids
BE624685A (cg-RX-API-DMAC7.html) * 1961-01-19
NL273690A (cg-RX-API-DMAC7.html) 1961-01-19 1900-01-01
US3941790A (en) * 1967-07-03 1976-03-02 National Research Development Corporation Bis diketopiperazines
JP2556026B2 (ja) * 1986-04-03 1996-11-20 日産化学工業株式会社 アルカリ廃水からの有用なカルボン酸の回収方法
US4764614A (en) * 1987-03-23 1988-08-16 Monsanto Company Process for preparing (S)(+)-4,4'(methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
JPS63243060A (ja) * 1987-03-31 1988-10-07 Nippon Mining Co Ltd エステル化物の回収方法
US4963679A (en) * 1988-02-17 1990-10-16 Erbamont, Inc. Process for preparing bis (3,5-dioxopiperazinyl) alkanes or alkenes
GB9122677D0 (en) * 1991-10-25 1991-12-11 Eurocetus Bv Process for preparing(s)(+)-4,4'-(1-methyl-1,2-ethanediyl)-bis(2,6-piperazinedione)
JPH11343267A (ja) * 1998-05-28 1999-12-14 Daikin Ind Ltd 含ハロゲンカルボン酸エステルの製造方法
WO2007053415A2 (en) * 2005-11-01 2007-05-10 Novartis Vaccines And Diagnostics Inc. Agents for the treatment of cardiac arrhythmias

Also Published As

Publication number Publication date
CN101563329B (zh) 2013-03-13
PE20081497A1 (es) 2008-10-30
TW200825068A (en) 2008-06-16
US8455641B2 (en) 2013-06-04
AT504621B1 (de) 2014-08-15
CN101563329A (zh) 2009-10-21
EP2099773B1 (de) 2017-07-05
UA102509C2 (uk) 2013-07-25
CA2670282A1 (en) 2008-05-29
WO2008061270A1 (de) 2008-05-29
ES2651245T3 (es) 2018-01-25
NO20092076L (no) 2009-08-17
UY30740A1 (es) 2008-07-03
JP2010510253A (ja) 2010-04-02
BRPI0719153A2 (pt) 2014-02-04
NZ577293A (en) 2011-12-22
AR063927A1 (es) 2009-02-25
MX2009005423A (es) 2009-07-17
IL198908A0 (en) 2010-02-17
AT504621A1 (de) 2008-06-15
RU2009123980A (ru) 2010-12-27
TWI491607B (zh) 2015-07-11
AU2007324322A1 (en) 2008-05-29
MA31015B1 (fr) 2009-12-01
US20100152447A1 (en) 2010-06-17
EP2099773A1 (de) 2009-09-16
KR20090119828A (ko) 2009-11-20
HK1133001A1 (en) 2010-03-12
ZA200903780B (en) 2014-11-26
CO6220854A2 (es) 2010-11-19

Similar Documents

Publication Publication Date Title
BRPI0618904A2 (pt) composto, composição farmacêutica, e, uso do composto
BRPI0717699A2 (pt) "composição e seus processos de preparação, uso de uma composição e uso coméstico de uma composição!
BRPI0806531A2 (pt) Composto, composição farmacêutica, agente terapêutico, e, uso do composto.
BRPI0720124A2 (pt) Composições farmacêuticas e seus métodos de uso.
BRPI0716171A2 (pt) composto, composiÇço farmacÊutica e uso de um composto.
WO2007034196A3 (en) Imaging agents comprising silicon
BRPI0407755B1 (pt) composiÇço catalÍtica, sua preparaÇço e uso
BRPI0911688A2 (pt) "compostos de pirimidina, composições e métodos de uso"
BRPI0813341A2 (pt) " uso de compostos, composições curáveis, e, uso de composições curáveis ".
BRPI0614162A2 (pt) dermocosmético, e, uso de um composto
IL189329A (en) The vaccine against dengue fever virus infection has been used and used
BRPI0922435A2 (pt) "composto de tiazolopiridina moduladores de sirtuina, composição farmacêutica compreendendo o mesmo e seu uso."
EP2030974A4 (en) HETEROCYCLIC NON-NUCLEOSIDE COMPOUNDS, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS, AND THEIR USE AS ANTIVIRAL AGENTS
BRPI0607545A2 (pt) composto, uso de um composto de fórmula i ou um sal farmaceuticamente aceitável do mesmo, e, composição farmacêutica
CL2007003672A1 (es) Compuestos derivados de heteroaril-pirrolidinil-cetona y heteroaril-piperidinil-cetona; composicion farmaceutica; y uso en el tratamiento de la depresion y ansiedad.
CL2007003348A1 (es) Procedimiento de preparacion de 4,4'-(1-metil-1,2-etandiil)-bis-(2,6-piperazindiona); compuesto intermediario; procedimiento de preparacion y uso.
DE602006013878D1 (de) Heterocyclische verbindungen, ihre herstellung und ihre verwendung als antibakterielle mittel
CL2007002619A1 (es) Compuestos derivados de 3-aza-biciclo[4.1.0]heptano; composicion farmaceutica; y uso en el tratamiento de la depresion.
BRPI0812766A2 (pt) 4-cloro-4-alcóxi-1,1,1-triflúor-2-butanonas, preparação das mesmas e uso das mesmas no preparo de 4-alcóxi-1,1,1-triflúor-3-buten-2-onas
CL2004001678A1 (es) Compuestos derivados de oxazolidinona; composicion farmaceutica; y uso de los compuestos como agentes bacterianos.
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0720323A2 (pt) composto, método de tratamento, composição farmacêutica e uso do composto
BRPI0810323A2 (pt) "combinação de ácido pirrolidona 5-carboxílico, uso do ácido pirrolidona 5-carboxílico, composição e seu uso"
CL2007002769A1 (es) Compuestos derivados de sulfonamida; procedimiento de obtencion; composicion farmaceutica; y uso en el tratamiento de la diabetes.
BRPI0922908A2 (pt) "composição compreendendo pelo menos dois cicloalquilmeticonas diferentes e uso deste".